Skip to main content
    O

    Opko Health Inc (OPK)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.62
    -0.06 (-3.57%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Opko Health Inc (OPK) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Opko Health reported revenue of $606.88M for the fiscal year ended Dec 31, 2025, down 14.9% from the year before. That year, net income was -$225.68M with a net margin of -37.2%, operating cash flow was -$178.54M and free cash flow was -$190.82M. The quarter ended Sep 30, 2026 had revenue of $65.41M and net income of -$53.53M.

    Revenue and Margins

    The operating margin was -19.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $1.12B, a compound annual decline of 6.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$606.88M-14.9%33.9%-19.3%-37.2%
    Dec 2024$713.14M-17.4%30.6%-21.3%-7.5%
    Dec 2023$863.50M-14.0%36.8%-18.2%-21.9%
    Dec 2022$1.00B-43.4%28.7%-22.5%-32.7%
    Dec 2021$1.77B+23.6%32.8%1.1%-1.7%
    Dec 2020$1.44B+59.1%37.7%4.0%2.1%
    Dec 2019$901.93M-8.9%36.5%-30.4%-34.9%
    Dec 2018$990.27M-43.4%38.9%-17.3%-15.5%
    Dec 2017$1.75B+56.5%64.5%-15.8%82.5%
    Dec 2016$1.12BN/A45.3%-8.6%-4.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$606.88M$713.14M$863.50M$1.00B$1.77B$1.44B$901.93M$990.27M$1.75B$1.12B
    Cost of revenue$400.94M$494.63M$545.37M$715.98M$1.19B$894.41M$572.48M$604.64M$620.13M$611.48M
    Gross profit$205.94M$218.51M$318.13M$288.22M$581.52M$541.00M$329.45M$385.63M$1.13B$506.01M
    Research and development$124.03M$105.21M$89.59M$73.89M$76.85M$75.32M$117.87M$125.59M$126.44M$113.87M
    Operating income-$117.41M-$152.06M-$157.02M-$226.25M$18.75M$57.71M-$274.05M-$171.20M-$276.44M-$96.55M
    Net income-$225.68M-$53.22M-$188.86M-$328.40M-$30.14M$30.59M-$314.93M-$153.04M$1.44B-$48.36M
    EBITDA-$50.85M$128.83M-$68.28MN/A$84.33M$156.67M-$190.36M-$69.09M-$163.62M$6.94M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$65.41M$163.58M$124.20M$148.45M$56.42M$156.81M$149.95M$183.64M$173.63M$182.19M$173.69M$181.91M
    Gross profit$42.06M$80.02M$45.76M$64.03M$35.05M$49.40M$42.62M$84.66M$40.13M$51.65M$42.07M$44.71M
    Operating income-$31.41M-$6.97M-$51.02M-$38.32M-$33.55M-$59.98M-$67.17M-$33.14M$14.22M-$61.67M-$71.47M-$69.05M
    Net income-$53.53M-$8.42M-$54.85M-$31.26M$21.63M-$148.44M-$67.61M$14.03M$24.89M-$10.30M-$81.84M-$66.48M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $341.70M by $27.37M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.93B$2.20B$2.01B$2.17B$2.40B$2.47B$2.31B$2.45B$2.59B$2.77B
    Current assets$581.88M$662.09M$309.48M$394.52M$823.01M$523.18M$324.05M$317.73M$348.86M$483.60M
    Cash and equivalents$369.07M$431.94M$95.88M$153.19M$134.71M$72.21M$85.45M$96.47M$91.50M$168.73M
    Total liabilities$663.98M$834.76M$622.48M$605.61M$714.59M$801.51M$694.51M$659.78M$746.33M$674.81M
    Short-term debt$10.25M$15.02M$27.29M$36.59M$14.70M$36.18M$9.62M$37.41M$11.93M$11.98M
    Long-term debt$331.45M$419.18M$214.32M$210.37M$187.94M$221.99M$211.21M$57.30M$29.16M$43.70M
    Shareholder equity$1.27B$1.37B$1.39B$1.56B$1.69B$1.67B$1.61B$1.79B$1.84B$2.09B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.88B$1.83B$1.86B$1.93B$2.00B$1.97B$2.13B$2.20B$2.26B$1.98B$1.97B$2.01B
    Total liabilities$764.08M$645.29M$652.19M$663.99M$690.02M$676.09M$816.66M$834.76M$852.69M$584.55M$721.21M$622.48M
    Cash and equivalents$390.22M$300.76M$341.88M$369.07M$415.20M$271.72M$436.00M$431.94M$406.40M$40.58M$75.64M$95.88M
    Shareholder equity$1.12B$1.18B$1.20B$1.27B$1.31B$1.30B$1.31B$1.37B$1.40B$1.40B$1.25B$1.39B
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$178.54M-$183.49M-$28.20M-$95.19M$38.34M$39.48M-$172.52M-$109.14M-$92.08M$32.05M
    Capital expenditures$12.28M$25.01M$16.27M$24.58M$32.16M$33.68M$12.74M$27.86M$46.52M$18.55M
    Free cash flow-$190.82M-$208.50M-$44.47M-$119.77M$6.18M$5.79M-$185.26M-$137.00M-$138.60M$13.50M
    Dividends paidN/AN/AN/AN/AN/AN/A$3.00KN/A$0$0
    Share repurchases$47.04M$90.22M$0$0N/AN/AN/AN/AN/AN/A
    Investing cash flow$230.30M$352.21M-$18.20M$91.04M$35.95M-$18.33M-$13.27M-$26.12M-$46.67M-$20.70M
    Financing cash flow-$118.06M$184.17M-$11.30M$22.97M-$10.35M-$35.08M$175.25M$140.91M$61.04M-$35.20M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$36.31M-$43.50M-$19.31M-$25.92M-$34.65M-$83.42M-$34.55M-$44.41M-$77.08M-$26.43M-$35.57M-$38.29M
    Capital expenditures$2.79M$3.00M$1.83M$2.67M$3.13M$3.28M$3.19M$5.41M$7.94M$7.22M$4.44M$3.02M
    Free cash flow-$39.10M-$46.50M-$21.14M-$28.59M-$37.78M-$86.70M-$37.75M-$49.82M-$85.02M-$33.65M-$40.01M-$41.32M
    Last 12 quarters

    Frequently Asked Questions About OPK

    What is Opko Health's annual revenue?

    Opko Health reported revenue of $606.88M for the fiscal year ended Dec 31, 2025.

    How fast is Opko Health's revenue growing?

    Revenue was down 14.9% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -15.5%.

    Is Opko Health profitable?

    No. Opko Health reported net income of -$225.68M for the fiscal year ended Dec 31, 2025, with a net margin of -37.2%.

    How much free cash flow does OPK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$178.54M minus capital expenditures of $12.28M produced free cash flow of -$190.82M.

    How much debt does Opko Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $331.45M, short-term debt of $10.25M and cash and equivalents of $369.07M.